Parallax Volatility Advisers
RSLS

Parallax Volatility Advisers’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History

Parallax Volatility Advisers’s Portfolio RSLS Stock Details RSLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed – – 4452
2018
Q3 		$0 Hold
1
– – ﹤0.01% 4027
2018
Q2 		$0 Hold
1
– – ﹤0.01% 3815
2018
Q1 		$2K Hold
1
– – ﹤0.01% 2060
2017
Q4 		$2K Buy
+1
New +$3.31K ﹤0.01% 3870

Other funds holding RSLS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Parallax Volatility Advisers's RSLS Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of ReShape Lifesciences Inc. Common Stock (RSLS) in Q4 2018, closing a stake of 1 share.

Parallax Volatility Advisers first reported a position in RSLS in Q4 2017 and held it in 4 quarters. The position peaked at $2K in Q1 2018. 2 funds tracked by Wall St. Rank hold RSLS as of Q4 2018.

  • Parallax Volatility Advisers reported no remaining ReShape Lifesciences Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1 ReShape Lifesciences Inc. Common Stock share in Q4 2018.
  • Parallax Volatility Advisers first reported a position in ReShape Lifesciences Inc. Common Stock in Q4 2017 and held it in 4 quarters.
  • Parallax Volatility Advisers's ReShape Lifesciences Inc. Common Stock position peaked at $2K in Q1 2018.
  • 2 funds tracked by Wall St. Rank held ReShape Lifesciences Inc. Common Stock as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.